MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bioorg.2026.109781

Медицинская библиотека · Bioorganic chemistry · 2026

Cyclic peptide-decorated PtIV-DCA prodrug triggers ferroptosis in glioblastoma via the disruption of energy metabolism.

Liu Haisheng, Feng Chenyao, Guan Miaoshui, Deng Yuyue, Li Yichen, Guo Yan, Jin Suxing

СтатьяПеревод пока не подготовлен

Аннотация

Glioblastoma (GBM), the most prevalent and aggressive primary malignant tumor of the central nervous system in adults, presents substantial therapeutic challenges due to its aberrant metabolic reprogramming. Integrins, a large family of cell surface receptors, play a pivotal role in the progression of gliomas, and cyclic peptides are known to target these receptors with high affinity and specificity. Herein, a metabolic-interfering PtIV complex DPR was constructed by anchoring a cyclic peptide (RGDfK)c and dichloroacetate (DCA) at the axial positions of cisplatin. DPR exhibited potent and selective cytotoxicity against U87-MG glioblastoma cells with high expression of integrin αvβ3. Mechanistic investigations revealed that DPR suppressed the expression of pyruvate dehydrogenase kinase (PDK), reduced the levels of lactate and ATP, induced mitochondrial DNA (mtDNA) damage, and impaired mitochondrial function, effectively disrupting energy homeostasis in GBM cells. Furthermore, this disruption of energy metabolism triggered ferroptosis, characterized by the accumulation of lipid peroxide (LPO) and malondialdehyde (MDA), the depletion of glutathione (GSH), alteration in mitochondrial morphology and the downregulation of glutathione peroxidase 4 (GPX4). Moreover, DPR demonstrated remarkable anti-angiogenesis activity in addition to its direct anticancer activity. Notably, DPR achieved remarkable antitumor efficacy with minimal systemic toxicity in a GL261-bearing mouse model. This study highlights DPR as a promising GBM-target PtIV complex that exerts therapeutic effects by synergistically interfering with energy metabolism and inducing ferroptosis, providing an innovative strategy to overcome therapeutic resistance in GBM.

Для цитирования: Liu Haisheng, Feng Chenyao, Guan Miaoshui, Deng Yuyue, Li Yichen, Guo Yan, Jin Suxing. Cyclic peptide-decorated PtIV-DCA prodrug triggers ferroptosis in glioblastoma via the disruption of energy metabolism.. Bioorganic chemistry. 2026. DOI: 10.1016/j.bioorg.2026.109781.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.